<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Lopez | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/taxtiger28/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/taxtiger28/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lopez.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">34c6595730f47694691d4971fb5ab9b9</guid>
				<title>Lopez posted an update: eded to confirm those results. Farnesyl pyrophosphate [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42266/</link>
				<pubDate>Sun, 09 Feb 2025 08:39:47 -0800</pubDate>

									<content:encoded><![CDATA[<p>eded to confirm those results. Farnesyl pyrophosphate synthase (FPPS) is a crucial enzyme for the synthesis of isoprenoids and the key target of nitrogen-containing bisphosphonates (N-BPs). N-BPs are potent and selective FPPS inhibitors that are used in the treatment of bone-related diseases, but have poor pharmacokinetic properties. Given the key&hellip;<span class="activity-read-more" id="activity-read-more-42266"><a href="http://www.nationalboardinstitute.com/activity/p/42266/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">55db1fc2d429708de2a427bd5d0056aa</guid>
				<title>Lopez posted an update: When compared with sham controls, high phosphorus CKD rats [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37068/</link>
				<pubDate>Mon, 03 Feb 2025 08:53:37 -0800</pubDate>

									<content:encoded><![CDATA[<p>When compared with sham controls, high phosphorus CKD rats were shown to be hyperphosphatemic (4.11 ± 0.23 versus 2.41 ± 0.22 mM Pi, p less then 0.0001) with elevated total plasma MVs (2.24 ± 0.37 versus 1.31 ± 0.24 × 108 per ml, p less then 0.01), showing increased CD144 expression (145 ± 25% of control value, p less then 0.0001), and enhan&hellip;<span class="activity-read-more" id="activity-read-more-37068"><a href="http://www.nationalboardinstitute.com/activity/p/37068/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">49d771f44bec4384de2a34cd0b60764b</guid>
				<title>Lopez posted an update: [This corrects the article doi [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35180/</link>
				<pubDate>Sat, 01 Feb 2025 08:35:08 -0800</pubDate>

									<content:encoded><![CDATA[<p>[This corrects the article doi 10.1590/0103-6440202003643].Lesions denominated fibro-osseous lesions of the jaw constitute a diversified group of disorders, in which the normal bone architecture is replaced by fibroblasts, collagen fibers and immature bone. At present, the World Health Organization recognizes four variants of these lesions, namely&hellip;<span class="activity-read-more" id="activity-read-more-35180"><a href="http://www.nationalboardinstitute.com/activity/p/35180/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d1c1e5b1d8de5342b37b52bcf59a5c9c</guid>
				<title>Lopez posted an update: The most downstream elements of the Hippo pathway, the TEAD [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33212/</link>
				<pubDate>Thu, 30 Jan 2025 08:30:17 -0800</pubDate>

									<content:encoded><![CDATA[<p>The most downstream elements of the Hippo pathway, the TEAD transcription factors, are regulated by several cofactors, such as Vg/VGLL1-3. Earlier findings on human VGLL1 and here on human VGLL3 show that these proteins interact with TEAD via a conserved amino acid motif called the TONDU domain. <a href="https://www.selleckchem.com/products/gdc-0994.html" rel="nofollow ugc">see more</a> Surprisingly, our studies reveal that the&hellip;<span class="activity-read-more" id="activity-read-more-33212"><a href="http://www.nationalboardinstitute.com/activity/p/33212/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">98850fa044aed5a200bf64600c20eb84</guid>
				<title>Lopez posted an update: 5 vs. 89.0 days). CONCLUSIONS Specific mutations in inhA and [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/27704/</link>
				<pubDate>Tue, 28 Jan 2025 09:57:04 -0800</pubDate>

									<content:encoded><![CDATA[<p>5 vs. 89.0 days). CONCLUSIONS Specific mutations in inhA and katG are associated with differences in resistance to other drugs and TSCC. Molecular testing may make it possible to tailor treatment and assess additional drug resistance risk according to specific mutation profile. Published by Oxford University Press for the Infectious Diseases&hellip;<span class="activity-read-more" id="activity-read-more-27704"><a href="http://www.nationalboardinstitute.com/activity/p/27704/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fb4f02b6d94c10b63751f84f06a7eb71</guid>
				<title>Lopez became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/27684/</link>
				<pubDate>Tue, 28 Jan 2025 09:53:37 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>